{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:55:28Z","timestamp":1789772128434,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ajem.2025.07.057","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T15:12:30Z","timestamp":1753456350000},"page":"165-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Underrecognized immune events in the emergency department among cancer patients on immune checkpoint inhibitors"],"prefix":"10.1016","volume":"97","author":[{"given":"Gamze K\u0131vrak","family":"Y\u0131lmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim Ula\u015f","family":"\u00d6zturan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An\u0131l","family":"Karakayal\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurettin \u00d6zg\u00fcr","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Yaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Pekdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2025.07.057_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajem.2025.07.057_bb0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ajem.2021.08.038","article-title":"Immune checkpoint inhibitors: an emergency medicine focused review","volume":"50","author":"Yoo","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2025.07.057_bb0015","doi-asserted-by":"crossref","first-page":"566","DOI":"10.5811\/westjem.2020.1.45898","article-title":"Oncologic emergencies: immune-based cancer therapies and complications","volume":"21","author":"Long","year":"2020","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.ajem.2025.07.057_bb0020","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajem.2025.07.057_bb0025","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of Immune-Related Adverse Events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajem.2025.07.057_bb0030","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/emp2.12209","article-title":"Diagnosis and management of immune-related adverse effects of immune checkpoint therapy in the emergency department","volume":"1","author":"Yeung","year":"2020","journal-title":"JACEP Open"},{"key":"10.1016\/j.ajem.2025.07.057_bb0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.emc.2021.08.011","article-title":"Immune-based therapies\u2014what the emergency physician needs to know","volume":"40","author":"Dubbs","year":"2022","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.ajem.2025.07.057_bb0040","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.mayocpiqo.2021.09.007","article-title":"Clinical presentations and outcomes of patients receiving immune checkpoint inhibitors presenting to the emergency department","volume":"5","author":"Castillo","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.ajem.2025.07.057_bb0045","first-page":"32","article-title":"Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab","author":"Kudu","year":"2024","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ajem.2025.07.057_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/curroncol28010007","article-title":"Emergency department utilization for patients receiving immune checkpoint inhibitors: a retrospective analysis of identification and outcomes for those presenting for immune-related adverse events","volume":"28","author":"Holstead","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ajem.2025.07.057_bb0055","first-page":"2029","article-title":"Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors","volume":"29","author":"Guven","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ajem.2025.07.057_bb0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejca.2020.02.025","article-title":"Emergency presentations in patients treated with immune checkpoint inhibitors","volume":"130","author":"Cooksley","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajem.2025.07.057_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/emermed-2023-213605","article-title":"Management and outcome of oncological patients under immune checkpoint inhibitors presenting at the emergency department","volume":"41","author":"Pini","year":"2024","journal-title":"Emerg Med J"},{"key":"10.1016\/j.ajem.2025.07.057_bb0070","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/emermed-2018-208091","article-title":"Immune checkpoint blockade toxicity among patients with cancer presenting to the emergency department","volume":"36","author":"Peyrony","year":"2019","journal-title":"Emerg Med J"},{"key":"10.1016\/j.ajem.2025.07.057_bb0075","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajem.2025.07.057_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jemermed.2024.12.005","article-title":"Evaluating the prognostic value of adding frailty to triage assessment in elderly patients with lower acuity presentations in the emergency department","volume":"73","author":"Ta\u015f","year":"2025","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2025.07.057_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00063-023-01036-5","article-title":"Prognostic value of early warning scores in patients presenting to the emergency department with exacerbation of COPD","volume":"119","author":"Do\u011fan","year":"2024","journal-title":"Medizinische Klinik-Intensivmedizin Und Notfallmedizin"},{"key":"10.1016\/j.ajem.2025.07.057_bb0090","series-title":"Common terminology criteria for adverse events (CTCAE) Version 5.0","author":"U.S Department of Health and Human Services","year":"2017"},{"key":"10.1016\/j.ajem.2025.07.057_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41416-024-02887-1","article-title":"Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review","volume":"132","author":"Jayathilaka","year":"2025","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajem.2025.07.057_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jemermed.2023.06.030","article-title":"Immune-related adverse events in patients on immunotherapy presenting to the emergency department: a retrospective cohort study","volume":"66","author":"Ruben","year":"2024","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2025.07.057_bb0105","first-page":"6365","article-title":"A nationwide survey among emergency physicians and oncologists to improve the management of immune checkpoint inhibitors toxicity","volume":"30","author":"Giamello","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ajem.2025.07.057_bb0110","first-page":"8","article-title":"Current diagnosis and management of immune related adverse events (irAEs) induced by immune checkpoint inhibitor therapy","author":"Kumar","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajem.2025.07.057_bb0115","first-page":"3","article-title":"Managing immune checkpoint inhibitor pneumonitis in the ICU. CHEST","author":"Montemayor","year":"2025","journal-title":"Crit Care"},{"key":"10.1016\/j.ajem.2025.07.057_bb0120","first-page":"8","article-title":"Immune-related adverse events as potential surrogates of immune checkpoint inhibitors\u2019 efficacy: a systematic review and meta-analysis of randomized studies","author":"Amoroso","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.ajem.2025.07.057_bb0125","first-page":"910","article-title":"Identifying emergency department symptom-based diagnoses with the unified medical language system. Western","author":"Slovis","year":"2019","journal-title":"J Emerg Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675725005182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675725005182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T21:25:03Z","timestamp":1759872303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675725005182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":25,"alternative-id":["S0735675725005182"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2025.07.057","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Underrecognized immune events in the emergency department among cancer patients on immune checkpoint inhibitors","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2025.07.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}